These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2867735)

  • 1. [Hemodynamics of erection: current pharmacological findings].
    Dorémieux J
    Ann Urol (Paris); 1985; 19(5):327-32. PubMed ID: 2867735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
    Asuar Aydillo S
    Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
    Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J
    Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intracavernous injections of vasoactive drugs. Evaluation of their diagnostic and therapeutic value in 65 cases of erectile impotence].
    Buvat J; Lemaire A; Marcolin G; Dehaene JL; Buvat-Herbaut M
    J Urol (Paris); 1986; 92(2):111-6. PubMed ID: 2876042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic and therapeutic applications of intracavernous injection of vasoactive drugs in impotence. Plea for the use of facilitator drugs. 2. Diagnostic and therapeutic applications].
    Buvat J; Buvat-Herbaut M; Lemaire A; Marcolin G
    J Urol (Paris); 1989; 95(2):89-96. PubMed ID: 2567319
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intracavernous injections: role in the diagnosis and therapy of problems in erection].
    Jardin A; Benoit G; Giuliano F
    Journ Annu Diabetol Hotel Dieu; 1993; ():359-74. PubMed ID: 8101244
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of 452 patients with erectile dysfunction treated by combinations of vasoactive agents by penile injection].
    Segenreich E; Israilov S; Shmueli J; Simon D; Baniel J; Livne P
    Harefuah; 1998 May; 134(9):673-8, 750. PubMed ID: 10909609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drugs for impotence].
    Lukkarinen O; Pelkonen R
    Duodecim; 1995; 111(8):771-6. PubMed ID: 8681837
    [No Abstract]   [Full Text] [Related]  

  • 9. Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.
    Purvis K; Brekke I; Christiansen E
    Int J Impot Res; 1996 Mar; 8(1):9-16. PubMed ID: 8735188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The therapeutic and diagnostic potentials of the intra-corpora cavernosa use of alprostadil, Edex, in patients with erectile dysfunction].
    Mzo EB; Dmitriev DG
    Ter Arkh; 1995; 67(10):45-8. PubMed ID: 8779105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intracavernous injection of papaverine hydrochloride for impotence in patients with spinal cord injury].
    Momose H; Natsume O; Yamamoto M; Suemori T; Yamada K
    Hinyokika Kiyo; 1987 Jul; 33(7):1065-9. PubMed ID: 3687629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracavernosal endothelin levels of impotent men before and after papaverine induced penile erection.
    Kadioğlu A; Memişoğlu K; Sazoya O; Tüzün E
    Arch Esp Urol; 1998 Sep; 51(7):739-40. PubMed ID: 9807905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Erection induced by papaverine].
    Török A; Székely J; Götz F
    Orv Hetil; 1988 Nov; 129(45):2401-3. PubMed ID: 3186244
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of electromyography of the corpora cavernosa (single potential analysis of cavernous electric activity--SPACE) as a technique for studying impotence].
    Salinas Casado J; Vírseda Chamorro M; Samblas García R; Esteban Fuertes M; Aristizábal Agudelo JM; Blázquez Izquierdo J; Delgado Martín JA; Resel Estévez L
    Arch Esp Urol; 1997 Jun; 50(5):512-9. PubMed ID: 9382594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and evaluation of nitrosylated alpha-adrenergic receptor antagonists as potential agents for the treatment of impotence.
    de Tejada IS; Garvey DS; Schroeder JD; Shelekhin T; Letts LG; Fernández A; Cuevas B; Gabancho S; Martínez V; Angulo J; Trocha M; Marek P; Cuevas P; Tam SW
    J Pharmacol Exp Ther; 1999 Jul; 290(1):121-8. PubMed ID: 10381767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Possibilities of treatment of erectile disorders by the administration of vasoactive substances into the penis using iontophoresis].
    Babula V; Sedmík J; Zvĕrina J
    Cas Lek Cesk; 1989 Oct; 128(43-44):1367-8. PubMed ID: 2598251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Penile extensibility and erectile function. Preliminary results].
    Bondil P; Louis JF; Daures JP; Costa P; Navratil H
    Ann Urol (Paris); 1990; 24(5):373-7. PubMed ID: 2252345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of erectile responses to vasoactive drugs by a variable amplitude oscillation device.
    Chun SS; Fenemore J; Heaton JP; Johnston B; Morales A
    Int J Impot Res; 1996 Dec; 8(4):221-5. PubMed ID: 8981171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologically induced penile erections in the assessment and treatment of erectile impotence: a preliminary study of 100 patients.
    Goonawardena SA; de Silva WA; Ketheeswaran T
    Ceylon Med J; 1997 Jun; 42(2):72-4. PubMed ID: 9257465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intracavernosa injections of drugs in erection disorders. Their clinical value apropos of 100 cases].
    Bondil P; Rigot JM; Nguyen Qui JL; Mazeman E
    J Urol (Paris); 1987; 93(9-10):547-8. PubMed ID: 3443767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.